Investor mix
3 investors on record; lead investors include 8VC.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 33% |
| Bank & private debt | 1 | 33% |
| Other / undisclosed | 1 | 33% |
Developer of therapeutics to treat opioid use disorders
3 investors on record; lead investors include 8VC.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 33% |
| Bank & private debt | 1 | 33% |
| Other / undisclosed | 1 | 33% |